Avamed Synergy — Seed · €800K

Alicante-based deeptech Avamed Synergy closed the first phase of its first investment round at €800,000 to advance Fluxus, an AI-based precision-medicine platform for oncological imaging and tumour characterisation. A group of private investors contributed €500,000 and ENISA added the remaining €300,000; no lead investor was named.